Protalix Biotherapeutics, Inc.
(NYSE Amex Equities : PLX)

( )
PLX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
DGXQuest Diagnostics, Inc. -5.36%73.304.3%$203.44m
LHLaboratory Corp. of America Holdings -2.51%113.102.4%$162.37m
SYNHSyneos Health, Inc. -1.94%34.320.0%$38.26m
NRCNational Research Corp. -5.62%42.290.0%$2.00m
AMEHApollo Medical Holdings, Inc. -2.10%12.140.0%$1.03m
PLXProtalix Biotherapeutics, Inc. 0.91%2.2156.8%$0.28m
IDXGInterpace Biosciences, Inc. -7.98%4.5024.1%$0.25m
PMDPsychemedics Corp. -3.71%5.450.7%$0.16m
BASIBioanalytical Systems, Inc. 4.05%3.340.2%$0.07m

Company Profile

Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.